Japan’s Chugai Pharma signs exclusive license agreement with GSK for anti-dengue virus antibody AID351
Japan’s Chugai Pharma signs exclusive license agreement with GSK for anti-dengue virus antibody AID351 August 20, 2026 |…
Browsing Tag